Annual report

Period2023-07-01 → 2024-06-30
Filed2024-09-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 145
MetricValuePeriodScopeSource row
Revenue¥5.2bn2023-07-01 → 2024-06-30Cons.Net sales
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30dCons.Net sales (5-year summary)
Revenue¥8.9bn2020-07-01 → 2021-06-30dCons.Net sales (5-year summary)
Revenue¥9.3bn2019-07-01 → 2020-06-30dCons.Net sales (5-year summary)
Operating income−¥610m2023-07-01 → 2024-06-30Cons.Operating income
Operating income¥726m2022-07-01 → 2023-06-30Cons.Operating income
Ordinary income−¥566m2023-07-01 → 2024-06-30Cons.Ordinary income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥920m2020-07-01 → 2021-06-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.1bn2019-07-01 → 2020-06-30dCons.Ordinary income loss (5-year summary)
Profit before tax−¥615m2023-07-01 → 2024-06-30Cons.Income before income taxes
Profit before tax¥725m2022-07-01 → 2023-06-30Cons.Income before income taxes
Net income (owners)−¥662m2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥562m2020-07-01 → 2021-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥732m2019-07-01 → 2020-06-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥663m2023-07-01 → 2024-06-30Cons.Profit loss
Net income¥456m2022-07-01 → 2023-06-30Cons.Profit loss
Total assets¥6.9bnat 2024-06-30Cons.Assets
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥8.5bnat 2022-06-30dCons.Total assets (5-year summary)
Total assets¥7.1bnat 2021-06-30dCons.Total assets (5-year summary)
Total assets¥7.4bnat 2020-06-30dCons.Total assets (5-year summary)
Total liabilities¥697mat 2024-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Net assets / equity¥6.2bnat 2024-06-30Cons.Net assets
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30dCons.Net assets
Net assets / equity¥6.2bnat 2021-06-30dCons.Net assets (5-year summary)
Net assets / equity¥5.8bnat 2020-06-30dCons.Net assets (5-year summary)
Cash and deposits¥4.8bnat 2024-06-30Cons.Cash and deposits
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
Cash & equivalents¥4.8bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30dCons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2021-06-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥4.5bnat 2020-06-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥881m2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥102m2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥107m2020-07-01 → 2021-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥830m2019-07-01 → 2020-06-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥14m2023-07-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥160m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥245m2021-07-01 → 2022-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥25m2020-07-01 → 2021-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥693m2019-07-01 → 2020-06-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥261m2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2021-07-01 → 2022-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥131m2020-07-01 → 2021-06-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥103m2019-07-01 → 2020-06-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-25.322023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.492020-07-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.972019-07-01 → 2020-06-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥238.28at 2024-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥266.41at 2023-06-30Cons.Net assets per share (5-year summary)
Net assets per share¥254.14at 2022-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥230.88at 2021-06-30dCons.Net assets per share (5-year summary)
Net assets per share¥214.39at 2020-06-30dCons.Net assets per share (5-year summary)
Equity ratio89.7%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30dCons.Equity to asset ratio (5-year summary)
Equity ratio75.7%at 2020-06-30dCons.Equity to asset ratio (5-year summary)
ROE6.6%2022-07-01 → 2023-06-30Cons.Rate of return on equity (5-year summary)
ROE12.8%2021-07-01 → 2022-06-30dCons.Rate of return on equity (5-year summary)
ROE9.7%2020-07-01 → 2021-06-30dCons.Rate of return on equity (5-year summary)
ROE13.8%2019-07-01 → 2020-06-30dCons.Rate of return on equity (5-year summary)
Employees90at 2024-06-30Cons.Number of employees
Employees98at 2023-06-30Cons.Number of employees
Employees100at 2022-06-30dCons.Number of employees
Employees104at 2021-06-30dCons.Number of employees
Employees105at 2020-06-30dCons.Number of employees
Revenue¥304m2023-07-01 → 2024-06-30StandaloneNet sales
Revenue¥377m2022-07-01 → 2023-06-30StandaloneNet sales
Revenue¥439m2021-07-01 → 2022-06-30dStandaloneNet sales (5-year summary)
Revenue¥425m2020-07-01 → 2021-06-30dStandaloneNet sales (5-year summary)
Revenue¥425m2019-07-01 → 2020-06-30dStandaloneNet sales (5-year summary)
Operating income−¥6m2023-07-01 → 2024-06-30StandaloneOperating income
Operating income¥81m2022-07-01 → 2023-06-30StandaloneOperating income
Ordinary income¥2m2023-07-01 → 2024-06-30StandaloneOrdinary income
Ordinary income¥87m2022-07-01 → 2023-06-30StandaloneOrdinary income
Ordinary income¥137m2021-07-01 → 2022-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥132m2020-07-01 → 2021-06-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥116m2019-07-01 → 2020-06-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥9m2023-07-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax¥87m2022-07-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥10m2023-07-01 → 2024-06-30StandaloneProfit loss
Net income¥142m2022-07-01 → 2023-06-30StandaloneProfit loss
Net income¥195m2021-07-01 → 2022-06-30dStandaloneNet income loss (5-year summary)
Net income¥288m2020-07-01 → 2021-06-30dStandaloneNet income loss (5-year summary)
Net income¥155m2019-07-01 → 2020-06-30dStandaloneNet income loss (5-year summary)
Total assets¥4.2bnat 2024-06-30StandaloneAssets
Total assets¥4.3bnat 2023-06-30StandaloneAssets
Total assets¥4.5bnat 2022-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.2bnat 2021-06-30dStandaloneTotal assets (5-year summary)
Total assets¥4.1bnat 2020-06-30dStandaloneTotal assets (5-year summary)
Total liabilities¥29mat 2024-06-30StandaloneLiabilities
Total liabilities¥21mat 2023-06-30StandaloneLiabilities
Net assets / equity¥4.1bnat 2024-06-30StandaloneNet assets
Net assets / equity¥4.3bnat 2023-06-30StandaloneNet assets
Net assets / equity¥4.3bnat 2022-06-30dStandaloneNet assets
Net assets / equity¥4.2bnat 2021-06-30dStandaloneNet assets (5-year summary)
Net assets / equity¥4.1bnat 2020-06-30dStandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2023-06-30StandaloneCash and deposits
EPS (basic)¥-0.42023-07-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.442022-07-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥7.472021-07-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.022020-07-01 → 2021-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥5.912019-07-01 → 2020-06-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥52022-07-01 → 2023-06-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥52021-07-01 → 2022-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥52020-07-01 → 2021-06-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥52019-07-01 → 2020-06-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥158.55at 2024-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥163.95at 2023-06-30StandaloneNet assets per share (5-year summary)
Net assets per share¥163.52at 2022-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥161.05at 2021-06-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥155.03at 2020-06-30dStandaloneNet assets per share (5-year summary)
Equity ratio99.3%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.6%at 2022-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.5%at 2021-06-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio99.6%at 2020-06-30dStandaloneEquity to asset ratio (5-year summary)
ROE3.3%2022-07-01 → 2023-06-30StandaloneRate of return on equity (5-year summary)
ROE4.6%2021-07-01 → 2022-06-30dStandaloneRate of return on equity (5-year summary)
ROE7.0%2020-07-01 → 2021-06-30dStandaloneRate of return on equity (5-year summary)
ROE3.8%2019-07-01 → 2020-06-30dStandaloneRate of return on equity (5-year summary)
Shares issued26,158,200at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2022-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2021-06-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,158,200at 2020-06-30dStandaloneTotal number of issued shares (5-year summary)
Employees11at 2024-06-30StandaloneNumber of employees
Employees7at 2023-06-30StandaloneNumber of employees
Employees9at 2022-06-30dStandaloneNumber of employees
Employees8at 2021-06-30dStandaloneNumber of employees
Employees8at 2020-06-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 94
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-07-01 → 2024-06-30¥798,000
Reconciling Itemsreconcilingdepreciation2023-07-01 → 2024-06-30¥231,000
Reconciling Itemsreconcilingrevenue2023-07-01 → 2024-06-30−¥43m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2024-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2024-06-30−¥44m
Reconciling Itemsreconcilingsegment assetsat 2024-06-30¥1.4bn
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2024-06-30−¥309m
Clinical Evidence Servicereportable segmentcapex2023-07-01 → 2024-06-30¥7m
Clinical Evidence Servicereportable segmentdepreciation2023-07-01 → 2024-06-30¥5m
Clinical Evidence Servicereportable segmentemployeesat 2024-06-3014 pure
Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2024-06-30¥236m
Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2024-06-30¥221m
Clinical Evidence Servicereportable segmentrevenue intersegment2023-07-01 → 2024-06-30¥15m
Clinical Evidence Servicereportable segmentsegment assetsat 2024-06-30¥298m
Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2024-06-30−¥70m
Functional Cosmetic Retailingreportable segmentcapex2023-07-01 → 2024-06-30¥6m
Functional Cosmetic Retailingreportable segmentdepreciation2023-07-01 → 2024-06-30¥11m
Functional Cosmetic Retailingreportable segmentemployeesat 2024-06-3027 pure
Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2024-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2024-06-30¥1.5bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2024-06-30¥2.6bn
Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2024-06-30−¥153m
Functional Food Retailingreportable segmentcapex2023-07-01 → 2024-06-30¥310,000
Functional Food Retailingreportable segmentdepreciation2023-07-01 → 2024-06-30¥9m
Functional Food Retailingreportable segmentemployeesat 2024-06-3022 pure
Functional Food Retailingreportable segmentrevenue2023-07-01 → 2024-06-30¥2.5bn
Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2024-06-30¥2.5bn
Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2024-06-30¥10m
Functional Food Retailingreportable segmentsegment assetsat 2024-06-30¥1.0bn
Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2024-06-30−¥158m
Functional Material Developmentreportable segmentdepreciation2023-07-01 → 2024-06-30¥928,000
Functional Material Developmentreportable segmentemployeesat 2024-06-307 pure
Functional Material Developmentreportable segmentrevenue2023-07-01 → 2024-06-30¥318m
Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2024-06-30¥299m
Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2024-06-30¥19m
Functional Material Developmentreportable segmentsegment assetsat 2024-06-30¥1.3bn
Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2024-06-30−¥13m
Health Care Support Servicereportable segmentdepreciation2023-07-01 → 2024-06-30¥353,000
Health Care Support Servicereportable segmentemployeesat 2024-06-309 pure
Health Care Support Servicereportable segmentrevenue2023-07-01 → 2024-06-30¥595m
Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2024-06-30¥595m
Health Care Support Servicereportable segmentsegment assetsat 2024-06-30¥382m
Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2024-06-30¥93m
—segment totalcapex2023-07-01 → 2024-06-30¥13m
—segment totaldepreciation2023-07-01 → 2024-06-30¥27m
—segment totalrevenue2023-07-01 → 2024-06-30¥5.2bn
—segment totalrevenue external2023-07-01 → 2024-06-30¥5.2bn
—segment totalrevenue intersegment2023-07-01 → 2024-06-30¥44m
—segment totalsegment assetsat 2024-06-30¥5.6bn
—segment totalsegment profit2023-07-01 → 2024-06-30−¥301m
Reconciling Itemsreconcilingcapex2022-07-01 → 2023-06-30¥244,000
Reconciling Itemsreconcilingdepreciation2022-07-01 → 2023-06-30¥217,000
Reconciling Itemsreconcilingrevenue2022-07-01 → 2023-06-30−¥25m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2023-06-30¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2023-06-30−¥26m
Reconciling Itemsreconcilingsegment assetsat 2023-06-30¥1.5bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2023-06-30−¥294m
Clinical Evidence Servicereportable segmentcapex2022-07-01 → 2023-06-30¥8m
Clinical Evidence Servicereportable segmentdepreciation2022-07-01 → 2023-06-30¥4m
Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2023-06-30¥617m
Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2023-06-30¥602m
Clinical Evidence Servicereportable segmentrevenue intersegment2022-07-01 → 2023-06-30¥15m
Clinical Evidence Servicereportable segmentsegment assetsat 2023-06-30¥427m
Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2023-06-30¥89m
Functional Cosmetic Retailingreportable segmentcapex2022-07-01 → 2023-06-30¥29m
Functional Cosmetic Retailingreportable segmentdepreciation2022-07-01 → 2023-06-30¥13m
Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2023-06-30¥3.9bn
Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2023-06-30¥3.9bn
Functional Cosmetic Retailingreportable segmentsegment assetsat 2023-06-30¥3.3bn
Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2023-06-30¥658m
Functional Food Retailingreportable segmentcapex2022-07-01 → 2023-06-30¥3m
Functional Food Retailingreportable segmentdepreciation2022-07-01 → 2023-06-30¥5m
Functional Food Retailingreportable segmentrevenue2022-07-01 → 2023-06-30¥2.5bn
Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2023-06-30¥2.5bn
Functional Food Retailingreportable segmentsegment assetsat 2023-06-30¥1.3bn
Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2023-06-30¥137m
Functional Material Developmentreportable segmentdepreciation2022-07-01 → 2023-06-30¥1m
Functional Material Developmentreportable segmentrevenue2022-07-01 → 2023-06-30¥501m
Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2023-06-30¥490m
Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2023-06-30¥11m
Functional Material Developmentreportable segmentsegment assetsat 2023-06-30¥1.4bn
Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2023-06-30¥43m
Health Care Support Servicereportable segmentdepreciation2022-07-01 → 2023-06-30¥935,000
Health Care Support Servicereportable segmentrevenue2022-07-01 → 2023-06-30¥553m
Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2023-06-30¥553m
Health Care Support Servicereportable segmentsegment assetsat 2023-06-30¥315m
Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2023-06-30¥93m
—segment totalcapex2022-07-01 → 2023-06-30¥39m
—segment totaldepreciation2022-07-01 → 2023-06-30¥25m
—segment totalrevenue2022-07-01 → 2023-06-30¥8.1bn
—segment totalrevenue external2022-07-01 → 2023-06-30¥8.1bn
—segment totalrevenue intersegment2022-07-01 → 2023-06-30¥26m
—segment totalsegment assetsat 2023-06-30¥6.8bn
—segment totalsegment profit2022-07-01 → 2023-06-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,263
ItemContextValueUnit
Description issued shares voting rightsCurrentYearInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with corporate auditors (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)取締役会長
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)石神賢太郎
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember1973-01-05
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000IshigamiKentaroMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMember
Original text (Japanese)代表取締役社長
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMember
Original text (Japanese)角田真佐夫
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMember1977-07-14
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000SumidaMasaoMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)取締役(非常勤)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)梶本 修身
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember1962-03-24
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000KajimotoOsamiMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000OkunoTakahitoMember
Original text (Japanese)取締役財務部長
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000OkunoTakahitoMember
Original text (Japanese)奥野 貴人
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000OkunoTakahitoMember1977-06-08
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000OkunoTakahitoMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000OkunoTakahitoMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000NakajimaMasakazuMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000NakajimaMasakazuMember
Original text (Japanese)中島 正和
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000NakajimaMasakazuMember1974-01-02
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000NakajimaMasakazuMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000NakajimaMasakazuMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000TimDENGMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000TimDENGMember
Original text (Japanese)鄧 旭
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000TimDENGMember1978-09-07
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000TimDENGMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000TimDENGMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000YamamotoHiroyukiMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000YamamotoHiroyukiMember
Original text (Japanese)山本 博幸
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000YamamotoHiroyukiMember1953-01-11
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000YamamotoHiroyukiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000YamamotoHiroyukiMember
Original text (Japanese)(注)3
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000HayashiKazuhiroMember
Original text (Japanese)監査役(常勤)
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000HayashiKazuhiroMember
Original text (Japanese)林 一弘
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E05367-000HayashiKazuhiroMember1952-12-29
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E05367-000HayashiKazuhiroMemberText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identitynon_consolidated 2023-06-30pass rounding
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2024-06-30pass
statement vs summary · revenueconsolidated 2022-07-01/2023-06-30pass
statement vs summary · revenueconsolidated 2023-07-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2022-07-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2023-07-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass